BOLT
Bolt Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.12
−6.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.14x
- Price / sales
- 3.07x
- Price / cash flow
- -0.46x
Enterprise value
- Enterprise value
- $18.5M
- EV / sales
- 3.93x
- EV / EBITDA
- -0.66x
- EV / EBIT
- -0.63x
- Market cap
- $14.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026